Literature DB >> 6204096

Exposure by desialylation of myeloid antigens on acute lymphoblastic leukemia cells.

H Stockinger, O Majdic, K Liszka, W Aberer, P Bettelheim, D Lutz, W Knapp.   

Abstract

The 3-fucosyl-N-acetyllactosamine structure, a sugar sequence contained in the human milk oligosaccharide lacto-N-fucopentaose III, is recognized by most of the granulocyte-specific monoclonal antibodies (MoAb) reported in the literature, including the six MoAb from our laboratory. Blast cells from patients with acute myeloblastic leukemia (AML) displayed a heterogeneous reaction pattern when they were exposed to MoAb against this moiety, and the proportion of reactive cells in individual cell samples was highly variable. The intensity of the reaction was strongly enhanced by neuraminidase treatment of AML blasts, and reactive structures were exposed on previously negative AML blast cells. Surprisingly, this granulocyte-associated antigen was exposed by desialylation not only on malignant myeloid precursor cells but also on common acute lymphoblastic leukemia cells. No such effect was seen when normal peripheral blood lymphocytes, lymphocytes from patients with chronic lymphatic leukemia, or blast cells from patients with B-cell acute lymphoblastic leukemia, acute erythroid leukemia, and acute megakaryoblastic leukemia were treated with neuraminidase.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204096

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Lectin activity as a marker for Hodgkin disease cells.

Authors:  E Paietta; R J Stockert; A G Morell; V Diehl; P H Wiernik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Expression of 3-fucosyl-N-acetyllactosamine on glia cells and its putative role in cell adhesion.

Authors:  B Niedieck; J Löhler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

Review 3.  Carbohydrates as antigenic determinants of glycoproteins.

Authors:  T Feizi; R A Childs
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

4.  Differences in the fine specificities of monoclonal (Class A) antibodies to human myeloid cells.

Authors:  H C Gooi; E F Hounsell; A Edwards; O Majdic; W Knapp; T Feizi
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

5.  Monoclonal antibodies to human myelomonocyte differentiation antigens in the diagnosis of acute myeloid leukemia.

Authors:  W Knapp; O Majdic; H Stockinger; P Bettelheim; K Liszka; U Köller; C Peschel
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

6.  Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies.

Authors:  H Budka; O Majdic; W Knapp
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

7.  Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors.

Authors:  H Budka; O Majdic
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?

Authors:  A N Stark; I D MacKarill; H J Limbert; P Evans; C S Scott
Journal:  Blut       Date:  1988-01

9.  Expression of CD15 in tumours of the nervous system.

Authors:  G Reifenberger; P Sieth; M Niederhaus; W Wechsler
Journal:  Histochem J       Date:  1992-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.